These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23276553)

  • 21. A comparative study of curcuminoids to measure their effect on inflammatory and apoptotic gene expression in an Aβ plus ibotenic acid-infused rat model of Alzheimer's disease.
    Ahmed T; Gilani AH
    Brain Res; 2011 Jul; 1400():1-18. PubMed ID: 21640982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and anti-Alzheimer properties of dimethylaminomethyl-substituted curcumin derivatives.
    Fang L; Gou S; Liu X; Cao F; Cheng L
    Bioorg Med Chem Lett; 2014 Jan; 24(1):40-3. PubMed ID: 24342238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Mechanisms of Action of Curcumin in Alzheimer's Disease.
    Tang M; Taghibiglou C
    J Alzheimers Dis; 2017; 58(4):1003-1016. PubMed ID: 28527218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of turmeric in Alzheimer's disease: curcumin or curcuminoids?
    Ahmed T; Gilani AH
    Phytother Res; 2014 Apr; 28(4):517-25. PubMed ID: 23873854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A chemical analog of curcumin as an improved inhibitor of amyloid Abeta oligomerization.
    Orlando RA; Gonzales AM; Royer RE; Deck LM; Vander Jagt DL
    PLoS One; 2012; 7(3):e31869. PubMed ID: 22442659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol, a neuroprotective supplement for Alzheimer's disease.
    Li F; Gong Q; Dong H; Shi J
    Curr Pharm Des; 2012; 18(1):27-33. PubMed ID: 22211686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of melatonin in Alzheimer-like neurodegeneration.
    Wang JZ; Wang ZF
    Acta Pharmacol Sin; 2006 Jan; 27(1):41-9. PubMed ID: 16364209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective effects of resveratrol in Alzheimer's disease.
    Rao YL; Ganaraja B; Joy T; Pai MM; Ullal SD; Murlimanju BV
    Front Biosci (Elite Ed); 2020 Jan; 12(1):139-149. PubMed ID: 31585875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcuminoids in neurodegenerative diseases.
    Kim DS; Kim JY; Han Y
    Recent Pat CNS Drug Discov; 2012 Dec; 7(3):184-204. PubMed ID: 22742420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease.
    Li L; Wang F; Jia X; Yao L; Liu Y
    Mini Rev Med Chem; 2024; 24(17):1590-1601. PubMed ID: 37929738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin and curcuminoids in quest for medicinal status.
    Grynkiewicz G; Ślifirski P
    Acta Biochim Pol; 2012; 59(2):201-12. PubMed ID: 22590694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.
    Li SY; Wang XB; Kong LY
    Eur J Med Chem; 2014 Jan; 71():36-45. PubMed ID: 24269515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies.
    Azzini E; Peña-Corona SI; Hernández-Parra H; Chandran D; Saleena LAK; Sawikr Y; Peluso I; Dhumal S; Kumar M; Leyva-Gómez G; Martorell M; Sharifi-Rad J; Calina D
    Phytother Res; 2024 Jun; 38(6):3169-3189. PubMed ID: 38616356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
    Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M
    J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease.
    Abdul-Rahman T; Awuah WA; Mikhailova T; Kalmanovich J; Mehta A; Ng JC; Coghlan MA; Zivcevska M; Tedeschi AJ; de Oliveira EC; Kumar A; Cantu-Herrera E; Lyndin M; Sikora K; Alexiou A; Bilgrami AL; Al-Ghamdi KM; Perveen A; Papadakis M; Ashraf GM
    Biofactors; 2024; 50(4):693-708. PubMed ID: 38226733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin.
    Pluta R; Furmaga-Jabłońska W; Januszewski S; Czuczwar SJ
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin: from chemistry to chemistry-based functions.
    Jitoe-Masuda A; Fujimoto A; Masuda T
    Curr Pharm Des; 2013; 19(11):2084-92. PubMed ID: 23116314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol as a therapeutic agent for Alzheimer's disease.
    Ma T; Tan MS; Yu JT; Tan L
    Biomed Res Int; 2014; 2014():350516. PubMed ID: 25525597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulatory effects of curcumin and resveratrol on lung carcinogenesis in mice.
    Malhotra A; Nair P; Dhawan DK
    Phytother Res; 2010 Sep; 24(9):1271-7. PubMed ID: 20041413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.